Long COVID biomarker study for UCSF participants
Part of Infections, Lungs & breathing clinical trials.
This study looks for signs of Long COVID in the blood and gut to better understand the condition. If you have Long COVID or were exposed to the virus without developing it, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had COVID-19 and now have Long COVID symptoms, or you were exposed to the virus but did not develop Long COVID.
- You are already part of the UCSF LIINC study or are willing to join and complete at least one visit.
- You are willing to have a gut biopsy (a small tissue sample taken from your intestine) as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
This study is testing a new blood test that looks for specific RNA markers to help diagnose long COVID. If you have new, lasting symptoms after a confirmed COVID-19 infection, this study may help find answers.
This study is testing a new, non-invasive way to diagnose Long COVID using a simple bioelectrical assessment. It might help if you've had COVID-19 and have been dealing with ongoing symptoms for 12 weeks or longer.
This study looks at how cells make energy in people with Long COVID compared to people who fully recovered. It involves a blood draw, a small muscle sample, and a skin biopsy to understand why symptoms last.
This study looks at how COVID-19 affects people in the long term. It aims to understand the lasting symptoms (often called long COVID) and how they impact your daily life. You may join if you have ongoing symptoms after COVID-19 that bother you or reduce your quality of life.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.